TY - JOUR
T1 - Serum surfactant protein D is increased in acute and chronic inflammation in mice
AU - Fujita, Masaki
AU - Shannon, John M.
AU - Ouchi, Hiroshi
AU - Voelker, Dennis R.
AU - Nakanishi, Yoichi
AU - Mason, Robert J.
N1 - Funding Information:
The study was supported by NIH grants HL56556, HL67671, and in part by HL29891.
PY - 2005/7/7
Y1 - 2005/7/7
N2 - Surfactant protein A (SP-A) and surfactant protein D (SP-D) are important components of innate immunity that can modify the inflammatory response. However, alterations and regulation of SP-A and SP-D in acute and chronic inflammation are not well defined. In addition, serum SP-D may serve as a biomarker of lung inflammation. We determined the expression of SP-A and SP-D in murine models. To study acute inflammation, we instilled bleomycin intrabronchially. To study chronic lung inflammation, we used a transgenic mouse that overexpresses tumor necrosis factor (TNF)-α under the control of the SP-C promoter. These mice have a chronic mononuclear cell infiltration, airspace enlargement, pulmonary hypertension, and focal pulmonary fibrosis. In acute inflammation model, levels of mRNA for all surfactant proteins were reduced after bleomycin administration. However, serum SP-D was increased from days 7 to 28 after instillation. In chronic inflammation model, SP-D mRNA expression was increased, whereas the expression of SP-A, SP-B and SP-C was reduced. Both serum and lung SP-D concentrations were increased in chronic lung inflammation. These data clarified profile of SP-A and SP-D in acute and chronic inflammation and indicated that serum SP-D can serve as a biomarker of lung inflammation in both acute and chronic lung injury in mice.
AB - Surfactant protein A (SP-A) and surfactant protein D (SP-D) are important components of innate immunity that can modify the inflammatory response. However, alterations and regulation of SP-A and SP-D in acute and chronic inflammation are not well defined. In addition, serum SP-D may serve as a biomarker of lung inflammation. We determined the expression of SP-A and SP-D in murine models. To study acute inflammation, we instilled bleomycin intrabronchially. To study chronic lung inflammation, we used a transgenic mouse that overexpresses tumor necrosis factor (TNF)-α under the control of the SP-C promoter. These mice have a chronic mononuclear cell infiltration, airspace enlargement, pulmonary hypertension, and focal pulmonary fibrosis. In acute inflammation model, levels of mRNA for all surfactant proteins were reduced after bleomycin administration. However, serum SP-D was increased from days 7 to 28 after instillation. In chronic inflammation model, SP-D mRNA expression was increased, whereas the expression of SP-A, SP-B and SP-C was reduced. Both serum and lung SP-D concentrations were increased in chronic lung inflammation. These data clarified profile of SP-A and SP-D in acute and chronic inflammation and indicated that serum SP-D can serve as a biomarker of lung inflammation in both acute and chronic lung injury in mice.
UR - http://www.scopus.com/inward/record.url?scp=20444493100&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=20444493100&partnerID=8YFLogxK
U2 - 10.1016/j.cyto.2005.02.006
DO - 10.1016/j.cyto.2005.02.006
M3 - Article
C2 - 15967375
AN - SCOPUS:20444493100
SN - 1043-4666
VL - 31
SP - 25
EP - 33
JO - Cytokine
JF - Cytokine
IS - 1
ER -